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Metallothionein in the Extracellular
Fluids as an Index of Cadmium Toxicity
by Zahir A. Shaikh* and Kimiko Hirayamat
In rats injected with 5 ,umole CdCl2/kg, 5 days/week, metallothionein was detected in plasma by gel
filtration chromatography asearly as four weeks. The mean renal concentration ofcadmium was 80,ug/g.
The excretion ofcadmium in urine at this time was rather low and amounted to 0.01% ofthe total dose.
The amount ofmetallothionein in plasma, as determined by uaCd-binding to the 10,000 molecular weight
fraction, increased markedly during week 14. Its excretion in urine, however, did not start until about 10
weeks, when the cadmium concentration in kidney approached a mean value of212,ug/g. Signs of renal
toxicity were evident from glucosuria and proteinuria which became severe during the next four weeks.
The excretion ofcadmium in urine increased markedly and the majority of it was in the form of metal-
lothionein. It is suggested that the appearance of metallothionein in plasma and urine can be used as
specific indices of cadmium poisoning and that the assay of the protein in these fluids may be useful in
screening for excessive cadmium exposure.
Introduction
The chronic exposure to cadmium is known to
produce renal tubular dysfunction in animals as well
as man when the concentration ofcadmium in renal
cortex exceeds 200 ug/g wet weight (1). Measure-
ment of cadmium concentration in urine or blood
usually reflects the extent of recent exposure.
Blood concentrations especially do not correlate
with the body burden. There is, therefore, no
threshold value for blood or urine cadmium con-
centration that can be used to predict the onset of
renal dysfunction (1). Once the tubular damage has
occurred in suspected populations offactory work-
ers, the confirmation is usually made by measuring
the urinary f32-microglobulin level (2, 3).
Most of the absorbed cadmium in the body is
sequestered by metallothionein which under normal
circumstances is an intracellular protein. However,
after long-term exposure to low levels ofcadmium,
the presence ofmetallothionein in plasma and urine
has been observed by others (4-6) and also in our
laboratory (7). The physiological functions of the
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protein are not yet fully understood. Ofthe various
functions that have been ascribed to the protein, the
two that have been advocated by Piscator and
Nordberg are protection from the toxicity of cad-
mium and transport of the metal from liver to the
kidneys (1). Contrary to this theory is the observa-
tion that intravenous administration of the protein
into animals results in nephrotoxicity, characteristic
ofcadmium poisoning (8, 9). It could be postulated,
therefore, that there is a connection between the
presence of metallothionein in the plasma and sub-
sequent renal toxicity in animals exposed to cad-
mium. The study described here provides for the
first time some insight into the existence of such a
relationship.
Materials and Methods
The study was carried out in Wistar rats injected
subcutaneously with 5 ,umole '"CdCl2/kg, 5 days
per week, for up to 14 weeks. The amount of cad-
mium in whole-body, tissues, and excreta was de-
termined by counting the radioactivity and con-
verting the values to mg cadmium using the specific
activity of the injection solution. It was assumed
that dietary intake ofthe metal resulted in negligible
increase in body burden. Glucose in urine was
tested with Multistix (Ames Company) and protein
was assayed by Tsuchiya's reagent as described by
Piscator (10). Analysis of metallothionein was car-
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The relationship between the injected dose of
cadmium and the body burden of the rats is shown
in Figure 1. With increasing dosage, smaller quan-
tities ofcadmium were retained. Between weeks 12
and 13, the rats accumulated and maintained the
maximum quantity of cadmium (8 mg). Thereafter,
the total retention declined although the exposure
continued for another week. It thus appears that the
maximum quantity of cadmium that can be ac-
cumulated by 300 to 350 g rats is 8 mg. The rats
were probably suffering from severe renal toxicity
during the last two weeks.
The rats were sacrificed at periodic intervals and
their liver and kidneys were assayed for '09Cd
(Table 1). It was found that the liver contained
about 60o of the injected dose during the first 12
weeks of exposure. However, during the next two
weeks there was a significant (20%) reduction in
4 6 8 10 12 cadmium content of the liver. A similar phenome- non was observed in the kidneys although the total
DOSE (mg Cd) cadmium content of the kidneys was almost ten
times lower than the liver. The above observations
tetween the injected dose and the body indicate that the reduction in body burden during ,ach point is a mean of4 to 19 animals. weeks 12-14 was caused mainly by the lower reten-
tion of cadmium by the liver and kidneys. Interest-
rof cadmium in liver and kidney. ingly, at all times about 80%o of the liver cadmium
and 70%o of the kidney cadmium were bound to
Dose,%5a metallothionein. This suggests that the decrease in
ver Kidney tissue,retention of cadmium is not caused by de-
* 3.4 6.3 ± 0.4 creased binding by metallothionein.
* 3.3 6.6 ± 0.4 When the cadmium content of the kidneys was
* 3.3 6.8 ± 0.3 expressed as Ag/g wet tissue weight, a rather in-
* 3.5 6.9 ± 0.4 teresting phenomenon was observed. As shown in
* 1.4 6.7 ± 0.3 Figure 2, the concentration of cadmium in kidney * 41.3" 5.0 ± 0.2b increased linearly up to ten weeks of exposure and
'alues. reached a mean value of 212 ,ug/g. The cadmium
from 4 week values (p <0.05). concentration remained above 200,ug/g during the
next four weeks. In chronic cadmium toxicity kid-
ney, plasma, and urine by the ney is regarded as the target organ and 200,g/g of
eviously (11). renal cortex is considered as the critical concentra-
tion (1). In the present study, the kidneys were not
Niscussion dissected into the cortex and the medulla. Assuming that the cortex contains about three times as much
ure to cadmium seemed to af- cadmium as the medulla (13) it is possible that these
the rats. Although the mean rats contained more than 300,mg cadmium/g cortex
il and cadmium-injected groups at 10 weeks and thereafter. The symptoms of cad-
icantly except after 14 weeks, mium toxicity became evident after 10 weeks, as
the cadmium-injected animals seen by the presence of glucosuria and proteinuria.
wer than that of the control During week 14, the urine contained as much as 100
week. Due to the small number mg protein/24 hr.
;his study, this point cannot be It was ofinterest to determine at what time period
wever, it does appear that the during the course of continuous exposure does the
mium may have started after metallothionein begin to appear in the plasma. The
sure. Loss of body weight has samples of plasma collected from rats after only
:ribed in rabbits by Nomiyama four weeks of exposure, when analyzed by gel fil-
tration chromatography, showed a small but distinct
Environmental Health Perspectives 268jium peak in the area where standard rat origin of the protein in plasma is not known. It is
lothionein is eluted (Fig. 3). The correspond- possible, though, that it may have been released
rhole kidney cadmium concentration was 80 from the liver and to some extent from other tissues
With the duration ofexposure, the amount of as well.
Lium in plasma increased. After 10 weeks, al- The elimination ofcadmium took place mainly via
rh some cadmium was bound to metallothio- the fecal route (Fig 4). At the end of the second
most of it was associated with larger molecu- week 6.4% of the total dose was excreted in the
Sight proteins, probably albumin andglobulins. feces. There was a linear increase in fecal excretion
14 weeks, however, about one-third of the of cadmium with the increase in exposure up to
iacadmium was bound to metallothionein. The week 10, and 9.7% of the dose was excreted in
feces. The fecal excretion was relatively high during
250 the next two weeks and was much more pro-
nounced during the final weeks. The liver, kidney
and other tissues which accumulate cadmium had
200 . I - apparently reached their saturation level and the
excess cadmium was simply not retained. Total
excretion during the 14 weeks accounted for almost
50
- 22% ofthe injected dose. Biliary and pancreatic se-
cretions, desquamation of intestinal epithelium
cells, and direct excretion of cadmium through the
100 intestinal wall may have all contributed to the loss
ofcadmium through the fecal route (14, 15).
Excretion of cadmium in urine was relatively
50 small, but it increased linearly during the eight weeks ofexposure (Fig. 5). The amount excreted in
urine was 0.01% of the total dose after four weeks
0 _ and it doubled in eight weeks. The appearance of
INURIA - - - + + + glucosuria and proteinuria after ten weeks was also
6URIA - - - + + + accompanied by relatively large excretion of cad-
SURIA - - mium in urine. By the end of 14 weeks, the rats had
4 6 8 10 12 14 excreted 7.25% of the injected dose in urine.
DURATION OF EXPOSURE (WEEKS) In orderto examine the form ofcadmium that was
being excreted in the urine, an aliquot of the fresh )Prsnoantrstf'n f aAm;11m ;n tha k-;.Anpu QV%A tlo ^1- riciuRE z. t-oncentration oii caumium in ine Kiuney anu ine oc-
currence ofrenal damage. Each point is the mean + S.D. of
data obtained from the three animals, except after 14 weeks,
when four rats were sacrificed.
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FIGuRE 3. Gel filtration chromatography of rat plasma. 1 ml of
plasma was applied to 0.9 x 60 cm column packed with
Sephadex G-75. The column was eluted with 1mM Tris-HCl,
pH 8.6 buffer, at 10 ml/hr. The eluant was monitored at 254
nm and 1 ml fractions were collected.
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FIGURE 4. Excretion ofcadmium in feces. Each point is the mean
+ S. D. of data from four rats.
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FIGURE 5. Excretion ofcadmium in urine. Each point is the mean
+ S. D. of data from four rats.
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FIGURE 6. Gel filtration chromatography of urine; 1 ml of clear
urine was applied to the column. Other details were the same
as described for Figure 3.
urine sample was separated by gel filtration chro-
matography. As seen in Figure 6, the urine from an
animal injected with cadmium for ten weeks sepa-
rated into three cadmium-binding peaks. Of these,
the middle peak corresponded with the elution vol-
ume of standard rat metallothionein. No such peak
ofcadmium was detected in urine samples analyzed
prior to 10 weeks. The excretion of cadmium as-
sociated with metallothionein increased as the
plasma metallothionein level increased and the
renal damage progressed. After 14 weeks about 90%o
of the cadmium in urine was excreted bound to
metallothionein. Previous work reported from our
laboratory has shown that intravenously injected
109Cd or 35S-labeled metallothionein is excreted in
rat urine as intact protein, and its excretion is de-
pendent on the injected dose (16, 17).
Conclusions
Under conditions of continuous exposure, it ap-
pears that more cadmium is excreted as the duration
of exposure is increased. Before the onset of renal
dysfunction, both fecal and urinary excretion are
proportional to the exposure. After the toxicity
symptoms appear, the excretion is considerably
higher through both routes. There is less retention
of the dose by liver, kidney and other tissues.
Renal toxicity occurs when the concentration of
cadmium in whole kidney exceeds 200,g/g. Metal-
lothionein appears in the urine along with other
proteins and its concentration increases with the
severity of the damage. In plasma, however, the
protein is present long before the onset of nephro-
toxicity. If metallothionein is monitored in plasma
of exposed individuals, it would be an excellent
screening tool for excessive exposure. Its presence
may serve as a warning against potential renal tox-
icity of cadmium. By measuring metallothionein in
urine from industrial workers and severely exposed
populations it may be possible to determine the ex-
tent ofdamage. Such atest would be more meaning-
ful and more specific than the measurement of 32-
microglobulin in urine. More work is needed to test
the applicability oftheobservations inanimals to the
human situations. There is also a need to develop a
sensitive and selective method to measure metal-
lothionein in biological fluids.
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